Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting System
Diabetes Spectr
.
2015 Nov;28(4):283-8.
doi: 10.2337/diaspect.28.4.283.
Authors
S Christopher Jones
1
,
Debra L Ryan
1
,
Valerie S W Pratt
1
,
Ali Niak
1
,
Allen D Brinker
1
Affiliation
1
U.S. Food and Drug Administration Office of Pharmacovigilance and Epidemiology and Office of New Drugs, Silver Spring, MD.
PMID:
26597395
PMCID:
PMC4647172
DOI:
10.2337/diaspect.28.4.283
No abstract available